Advertisement
Advertisement
FENC
Fennec Pharmaceuticals Inc. Common Stock
10.62
USDSponsored
-0.16
-1.48%
Sep 18, 15:59 UTC -4
Closed
After-Market
10.60
-0.02
-0.19%
FENC Earnings Reports
Positive Surprise Ratio
FENC beat 17 of 36 last estimates.
47%
Next Report
Date of Next Report
Nov 11, 2026
Estimate for Q3 26 (Revenue/ EPS)
$19.19M
/$0.09
Implied change from Q2 26 (Revenue/ EPS)
+7.36%
/+80.00%
Implied change from Q3 25 (Revenue/ EPS)
+53.99%
/-550.00%
Fennec Pharmaceuticals Inc. Common Stock earnings per share and revenue
On Aug 11, 2026, FENC reported earnings of 0.05 USD per share (EPS) for Q2 26, beating the estimate of 0.01 USD, resulting in a 400.00% surprise. Revenue reached 17.87 million, compared to an expected 16.44 million, with a 8.72% difference. The market reacted with a +16.82% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 6 analysts forecast an EPS of 0.09 USD, with revenue projected to reach 19.19 million USD, implying an increase of 80.00% EPS, and increase of 7.36% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Therapeutics Inc. Common Stock
Report Date
Sep 08, 2026 For Q3 26
Estimate
-$0.43
Actual
-$0.47
Surprise
-7.16%
Anixa Biosciences, Inc.
Report Date
Sep 09, 2026 For Q3 26
Estimate
-$0.08
Actual
-$0.08
Surprise
+8.78%
Alzamend Neuro, Inc. Common Stock
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.57
Actual
-$0.68
Surprise
-19.05%
FAQ
What were Fennec Pharmaceuticals Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Fennec Pharmaceuticals Inc. Common Stock reported EPS of $0.05, beating estimates by 400%, and revenue of $17.87M, 8.72% above expectations.
How did the market react to Fennec Pharmaceuticals Inc. Common Stock's Q2 2026 earnings?
The stock price moved up 16.82%, changed from $10.94 before the earnings release to $12.78 the day after.
When is Fennec Pharmaceuticals Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 11, 2026.
What are the forecasts for Fennec Pharmaceuticals Inc. Common Stock's next earnings report?
Based on 6
analysts, Fennec Pharmaceuticals Inc. Common Stock is expected to report EPS of $0.09 and revenue of $19.19M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.